knowcompoundsrosuvastatin
Specimen compound organic compoundPlate I
Rosuvastatin

- Formula
- C22H28FN3O6S
- Molar mass
- 481.546 g/mol
- ChEBI
- CHEBI:38545
- PubChem CID
- 446157
- InChIKey
- BPRHUIZQVSMCRT-VEUZHWNKSA-N
↓ lowered
01 · the evidence, ordered
What the evidence says
- Moderate
×1.60
Labels
CompoundInspector
Rosuvastatin
36 compounds on the outer ring, not drawn
Keys
← → round a ring↑ ↓ out and inEnter selecte the outer ringf fit to view+ − zoomEsc clearclick a node to select it
02 · findings
What rosuvastatin moved, and by how much
- MD mean difference. Brackets: the interval as reported.
- Dose studied: as its paper gave it.
- Evidence strength: computed from the study. How it is computed
- Diastolic blood pressureMoved: lowersEffect, as reportedMD−2.12[−3.72 to −0.52]Evidence: ModeratePaper: PMID 348183502021
- Who
- Patients with hypertension and dyslipidemia treated with rosuvastatin 20 mg/day plus antihypertensive agents (an ARB, or an ARB plus a calcium channel blocker), compared with the same antihypertensive background alone
- Dose studied
- rosuvastatin 20 mg/day
The patients treated with rosuvastatin in addition to antihypertensives had a significantly lower DBP (MD = −2.12 mmHg; 95% CI = −3.72 to −0.52; Pfixed-effects model = 0.009; I 2 = 0%, Pheterogeneity = 0.97) than the patients treated with antihypertensives alone.”
Quoted verbatim from Antihypertensive effects of rosuvastatin in patients with hypertension and dyslipidemia: A systemic review and meta-analysis of randomized studies.meta-analysis · 8 weeksPermalink
No row matches these filters.
No dose is advised.
- MD mean difference. Brackets: the interval as reported.
- Dose studied: as its paper gave it.
- Evidence strength: computed from the study. How it is computed
03 · identity
Structure
- Charge
- 0
- SMILES
- CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)O
04 · figures · 1 plate
Plates

fig. 4Rosuvastatin · MS2 [M+H]+ LC-ESI-ITFT positive · MassBank MSBNK-Eawag-EA280206 (Stravs M, CC BY)
05 · the record
Sources
788
papers screened for rosuvastatin
- admitted
- 1
- read and discarded
- 157
- not read yet
- 630
- Documented interactions
- None reported
Sources cited
1 paper · 1 finding